New study reports reduced anxiety and depression from low-dose CBD

A new study from the US has found that the use of CBD products, even at a low dose, was linked to reductions in both anxiety and depression.

The study led by non-profit organisation Realm of Caring (RoC), examined the benefits of medicinal cannabis products for individuals with anxiety and depression.

The data published in the medical journal Frontiers in Psychiatry, showed that individuals who initiated use of artisanal CBD products or continued use of CBD products at follow-up endorsed significant reductions in both anxiety and depression, improved sleep, and less pain compared with those not using CBD.

Researchers sourced data from an online web survey– RoC’s Observational Research Registry (ORR) – conducted over a four-year period (2016-2020) focusing on participants’ self-reported anxiety and depression symptoms, and the need for an assessment on non-pharmaceutical CBD products widely available to consumers. 

RoC was co-founded by Paige Figi, the mother of Charlotte Figi, whose story inspired the launch of global CBD brand Charlotte’s Web. The organisation is dedicated to cannabinoid research and improving access to cannabis-based therapies for those who could benefit.

Dr Nicolas Schlienz, research director for RoC, said the findings addressed misconceptions that CBD needs to be consumed in high doses to be effective for relieving symptoms. 

“The biggest misconception this study addresses is that CBD doses need to be between 400-600 mg before positive psychiatric effects can be achieved,” said Dr Schlienz.

“We observed positive effects in people taking an average of only about 60 mg per day, one tenth of that dose.”

 For information on joining RoC’s ongoing research www.realmofcaring.org